Cargando…

Impact of FKBP52 on cell proliferation and hormone‐dependent cancers

FK506 binding protein 52 (FKBP52) (gene name FKBP4) is a 52 kDa protein that belongs to the FKBP family; it binds to the immunosuppressant FK506 and has proline isomerase activity. In addition to its FK domain‐containing peptidylprolyl isomerase activity, FKBP52 also acts as a cochaperone through th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanaki, Shunsuke, Shimada, Midori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323096/
https://www.ncbi.nlm.nih.gov/pubmed/37026526
http://dx.doi.org/10.1111/cas.15811
_version_ 1785068894592958464
author Hanaki, Shunsuke
Shimada, Midori
author_facet Hanaki, Shunsuke
Shimada, Midori
author_sort Hanaki, Shunsuke
collection PubMed
description FK506 binding protein 52 (FKBP52) (gene name FKBP4) is a 52 kDa protein that belongs to the FKBP family; it binds to the immunosuppressant FK506 and has proline isomerase activity. In addition to its FK domain‐containing peptidylprolyl isomerase activity, FKBP52 also acts as a cochaperone through the tetratricopeptide repeat domain that mediates binding to heat shock protein 90. Previous studies have reported that FKBP52 is associated with hormone‐dependent, stress‐related, and neurodegenerative diseases, revealing its diverse functions. In particular, the effects of FKBP52 on cancer have attracted considerable attention. FKBP52 promotes the growth of hormone‐dependent cancers by activating steroid hormone receptors. Recent studies have shown that the expression of FKBP52 is increased not only in steroid hormone‐dependent cancer cells but also in colorectal, lung, and liver cancers, revealing its diverse functions that contribute to cancer growth. This review summarizes reports related to hormone‐dependent cancer and cell proliferation in terms of the structure of FKBP52 and its function on interacting molecules.
format Online
Article
Text
id pubmed-10323096
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103230962023-07-07 Impact of FKBP52 on cell proliferation and hormone‐dependent cancers Hanaki, Shunsuke Shimada, Midori Cancer Sci Review Articles FK506 binding protein 52 (FKBP52) (gene name FKBP4) is a 52 kDa protein that belongs to the FKBP family; it binds to the immunosuppressant FK506 and has proline isomerase activity. In addition to its FK domain‐containing peptidylprolyl isomerase activity, FKBP52 also acts as a cochaperone through the tetratricopeptide repeat domain that mediates binding to heat shock protein 90. Previous studies have reported that FKBP52 is associated with hormone‐dependent, stress‐related, and neurodegenerative diseases, revealing its diverse functions. In particular, the effects of FKBP52 on cancer have attracted considerable attention. FKBP52 promotes the growth of hormone‐dependent cancers by activating steroid hormone receptors. Recent studies have shown that the expression of FKBP52 is increased not only in steroid hormone‐dependent cancer cells but also in colorectal, lung, and liver cancers, revealing its diverse functions that contribute to cancer growth. This review summarizes reports related to hormone‐dependent cancer and cell proliferation in terms of the structure of FKBP52 and its function on interacting molecules. John Wiley and Sons Inc. 2023-04-27 /pmc/articles/PMC10323096/ /pubmed/37026526 http://dx.doi.org/10.1111/cas.15811 Text en © 2023 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Review Articles
Hanaki, Shunsuke
Shimada, Midori
Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
title Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
title_full Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
title_fullStr Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
title_full_unstemmed Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
title_short Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
title_sort impact of fkbp52 on cell proliferation and hormone‐dependent cancers
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323096/
https://www.ncbi.nlm.nih.gov/pubmed/37026526
http://dx.doi.org/10.1111/cas.15811
work_keys_str_mv AT hanakishunsuke impactoffkbp52oncellproliferationandhormonedependentcancers
AT shimadamidori impactoffkbp52oncellproliferationandhormonedependentcancers